406 results on '"Hählen K"'
Search Results
2. In-Vitro Cellular Drug Resistance in Acute Non-Lymhoblastic Leukemia: Comparisons Between Adults and Children
3. BCL-2 Expression in Childhood Leukemia Versus Spontaneous Apoptosis, Drug Induced Apoptosis, and in vitro Drug Resistance
4. Effects of Growth Factors In Vitro on Acute Lymphoblastic Leukemia Cells
5. Molecular Biology of Acute Lymphoblastic Leukemia: Implications for Detection of Minimal Residual Disease
6. Prognostic Value of Hypoxanthine-Guanine Phosphoribosyl-Transferase in Childhood Leukemia
7. Antileukemic Activity In Vitro of Mitoxantrone and Anthracyclines in Untreated Childhood Acute Lymphoblastic Leukemia
8. Cytostatic Drug Resistance in Childhood Relapsed Acute Lymphoblastic Leukemia
9. Childhood Acute Lymphoblastic Leukemia and Acute Non-Lymphoblastic Leukemia: Differences in Cellular Drug Resistance, with Emphasis on Glucocorticoids — A Pilot Study
10. Vitamin A Does Not Enhance the Antileukemic Effect of Vincristine, Daunorubicin, and 6-Thioguanine in Acute Lymphoblastic Leukemia Cells
11. Differences in Immunoglobulin and T-Cell Receptor Gene Rearrangement Patterns in Acute Lymphoblastic Leukemia Between Diagnosis and Relapse
12. Six Months of Intensive Chemotherapy for Childhood ANLL: Preliminary Results of the Study ANLL-87 of the Dutch Childhood Leukemia Study Group
13. Cellular Drug Sensitivity of Immunophenotypic Subgroups of Childhood Acute Lymphoblastic Leukemia
14. Correlation of In Vitro Drug Resistance Assessed by the MTT Assay with Long Term Clinical Outcome in Childhood Acute Lymphoblastic Leukemia
15. Drug Resistance in Children with Relapsed Acute Lymphoblastic Leukemia
16. In Vitro Drug Resistance in Childhood Acute Lymphoblastic Leukemia in Relation to Age and Immunophenotype
17. Dutch Childhood Leukemia Study Group: Early Results of Study ALL VI (1984–1988)
18. Double Marker Analysis for Terminal Deoxynucleotidyl Transferase and Myeloid Antigens in Acute Nonlymphocytic Leukemia Patients and Healthy Subjects
19. Interleukin-10 and Soluble Tumor Necrosis Factor Receptors in Cerebrospinal Fluid of Children with Bacterial Meningitis
20. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples
21. Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials
22. Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia
23. Causes of death – other than progressive leukemia – in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience
24. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL
25. Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR
26. t(7;12)(q36;p13) and t(7;12)(q32;p13) – translocations involving ETV6 in children 18 months of age or younger with myeloid disorders
27. Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia
28. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy
29. Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemia
30. Immunophenotypic and immunogenotypic characteristics of TCRγδ+ T cell acute lymphoblastic leukemia
31. Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease
32. Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease
33. Cranial irradiation is the major cause of learning problems in children treated for leukemia and lymphoma: a comparative study
34. Large interindividual differences in cellular sensitivity to calicheamicin may influence gemtuzumab ozogamicin response in acute myeloid leukemia
35. The prognosis of oncologic patients in the pediatric intensive care unit
36. Growth of children with Langerhans cell histiocytosis
37. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples
38. Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin
39. MOST ADULT SURVIVORS OF CHILDHOOD CANCER HAVE A VERY GOOD GENERAL FEELING OF WELLBEING: P.U.010
40. Differences in the prevalence of PTPN11 mutations in FAB M5 paediatric acute myeloid leukaemia
41. BCL-2 Expression in Childhood Leukemia Versus Spontaneous Apoptosis, Drug Induced Apoptosis, and in vitro Drug Resistance
42. Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance
43. Tel/aml1 fusion is not a prognostic factor in dutch childhood acute lymphoblastic leukaemia
44. Molecular Biology of Acute Lymphoblastic Leukemia: Implications for Detection of Minimal Residual Disease
45. Effects of Growth Factors In Vitro on Acute Lymphoblastic Leukemia Cells
46. Cellular Drug Sensitivity of Immunophenotypic Subgroups of Childhood Acute Lymphoblastic Leukemia
47. Drug Resistance in Children with Relapsed Acute Lymphoblastic Leukemia
48. In Vitro Drug Resistance in Childhood Acute Lymphoblastic Leukemia in Relation to Age and Immunophenotype
49. Correlation of In Vitro Drug Resistance Assessed by the MTT Assay with Long Term Clinical Outcome in Childhood Acute Lymphoblastic Leukemia
50. Double Marker Analysis for Terminal Deoxynucleotidyl Transferase and Myeloid Antigens in Acute Nonlymphocytic Leukemia Patients and Healthy Subjects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.